Z. Liu

Resistance to HIV-1 infection. Multicenter AIDS Cohort Study.

J. Phair, R. Detels, J. Kan, 1994, Journal of acquired immune deficiency syndromes.

Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.

R. Detels, A. Kaplan, J. Giorgi, 1995, The Journal of infectious diseases.

Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.

R. Detels, W. Cumberland, J. Giorgi, 1993, Journal of acquired immune deficiency syndromes.

A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression.

R. Detels, B. Visscher, J. Cherry, 1994, The Journal of infectious diseases.

CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.

R. Detels, A. Kaplan, W. Cumberland, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.

R. Detels, W. Cumberland, J. Giorgi, 1996, Cytometry.

Persistent cytomegalovirus infection of semen increases risk of AIDS.

R. Detels, J. Giorgi, B. Visscher, 1994, The Journal of infectious diseases.

A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand.

C. Ware, J. Ashwell, Y. Yang, 1997, Blood.